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ABSTRACT 
Near-infrared (NIR) responsive nanoparticles are of great interest in the biomedical 
field as antennas for photothermal therapy and also as triggers for on-demand drug 
delivery. The present work reports the preparation of hollow gold nanoparticles 
(HGNPs) with plasmonic absorption in the NIR region covalently bound to a 
thermoresponsive polymeric shell than can be used as an on-demand drug delivery 
system for the release of analgesic drugs. The photothermal heating induced by the 
nanoparticles is able to produce the collapse of the polymeric shell thus generating the 
release of the local anesthetic bupivacaine in a spatiotemporally controlled way. Those 
HGNPs contain a 10 wt.% of polymer and present excellent reversible heating under 
NIR light excitation. Bupivacaine released at physiological temperature (37 ºC) showed 
a pseudo-zero order release that could be spatiotemporally modified on-demand after 
applying several pulses of light/temperature above and below the lower critical solution 
temperature (LCST) of the polymeric shell. Furthermore, the nanomaterials obtained 
did not displayed detrimental effects on four mammalian cell lines at doses up to 0.2 
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mg/mL. From the results obtained it can be concluded than this type of hybrid 
thermoresponsive nanoparticle can be used as an externally activated on-demand drug 
delivery system. 
 
Keywords: thermoresponsive polymer; phototriggerable; on-demand; plasmonic 
nanoparticles; anesthetic drug  
 
1. Introduction 
Hybrid systems composed of inorganic nanoparticles encapsulated in an organic 
shell are promising materials that have been recently developed showing unique 
properties and functions. The functionality of these systems depends on the shape and 
size of the inorganic core and on the type of organic shell that provides the construct 
with the surface properties desired for the envisaged application. Moreover, the 
combination of inorganic nanoparticles and polymeric shells might produce 
complementary and novel properties that are not found in their individual components. 
Consequently hybrid nanocomposites composed of metal [1-3], metal oxide [4-6] or 
non-metal [7-10] nanoparticles have been used for different applications. On-demand 
drug delivery is required when dosing and timing would produce an improved outcome 
of the pathology compared to conventional sustained or controlled delivery. This 
methodology has the advantage of controlling local dosing so that the drug is released at 
a specific time and with a chosen dose, moreover the dose supplied can be modified 
according to the patient needs. For instance, in the treatment of chronic pain or 
hormonal disorders the doses required can be supplied depending on the disease 
progresses. Pulsatile release of drugs can also be useful in the treatment of diabetes 
through on demand insulin delivery [11]. Nanomaterials have great potential as on-
demand drug delivery systems as they allow reduced toxicity, side effects and provide 
with a more rational usage of the carried drug reducing under or overdose. Different 
external triggers can be used to activate the release including physical stimuli (e.g., 
light, temperature, alternating magnetic fields, ultrasounds, etc.) and biochemical 
stimuli (e.g., acidic environment, redox potential, presence of specific moieties, etc.). In 
this regard, proteins were efficiently loaded into pH and reductive environment 
responsive nanosized polymersomes prepared from polyethylene glycol (PEG)-based 
block copolymers. The release of proteins was triggered specifically at endosomal pH 
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(i.e., pH 6) or under the reductive conditions of cytosol (10 mM dithiothreitol), so the 
amount released was significantly higher than that reached at physiological conditions 
(pH 7.4 and 37 ºC) [12]. Micelles composed of dendrimers and boronic acid or catechol 
at the interfase were developed for the release of the chemotherapeutic drug paclitaxel 
upon the addition of mannitol or under acidic conditions (i.e., pH 5) [13]. This system is 
also sensitive to oxidizing agents being interesting for oxidation-assisted triggered 
release [14]. In addition, hybrid nanomaterials triggered by temperature have been 
widely used in biomedicine, particularly in cancer treatment [7, 15-17]. Magnetic 
nanoparticles combined with thermoresponsive polymers allow to deliver heat 
promoting drug desorption locally under the presence of an alternating magnetic field to 
be potentially used not only in triggered drug delivery but also in hyperthermal therapy 
[15, 16, 18]. 
Thermoresponsive copolymers derived from oligo (ethylene glycol) 
methacrylate with reversible transition above and below their LCST are biocompatible 
materials suitable as injectable drug delivery systems [19-21]. Another transition-
reversible thermosensitive polymer, such as poly(N-isopropylacrylamide) (PNIPAM), 
has been widely used in different biomedical applications including triggered drug 
delivery [22], biosensing [23], cell culturing [24], encapsulation [25], and tissue 
engineering [26]. However, it presents some disadvantages, such as lower 
biocompatibility and hysteresis in its phase transition, compared to OEGMA-based 
copolymers [27-29]. Lutz et al. [30] described the preparation of thermoresponsive 
copolymers based on OEGMA using atom transfer radical polymerization (ATRP). 
They reported the ATRP of OEGMA and MEO2MA copolymers initiated by methyl 2-
bromopropionate (MBP) using a chloride-based CuCl/bipy catalyst, leading to a good 
control in the polymerization. These polymers are soluble in water and undergo a 
transition to water-insoluble materials above their LCST. This transition temperature 
can be tuned by changing the oligo (ethylene glycol) methyl ether methacrylate 
(OEGMA) and di (ethylene glycol) methyl ether methacrylate (MEO2MA) monomer 
ratio [30]. This phenomenon has been used for the remote-controlled drug delivery [31-
33]. The release of encapsulated drugs can be triggered in response to a temperature 
driven stimuli induced by irradiation of light at the extinction peak of the nanomaterial 
inorganic core. Surface plasmonic resonance in nanoparticles induces localized heating 
within the thermoresponsive shell. When the temperature rises above the LCST of the 
polymer, the polymer shell collapses resulting in an on-demand burst release of drugs 
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trapped on it as opposed to a diffusion-controlled release. Compared to visible light, 
irradiation with NIR light allows deeper tissue penetration and diminishes tissue injuries 
potentially incurred in the patient [34]. Consequently, NIR activated drug delivery 
systems have been previously used to promote controlled delivery of drugs entrapped 
into thermoresponsive polymers [35, 36]. For example, Zhang et al. have reported the 
release of doxorubicin in a controlled manner from mesoporous-silica-coated gold 
nanorods modified with PNIPAM after activation upon NIR light irradiation [35]. 
However, to the best of our knowledge, the triggered release of an encapsulated drug 
from plasmonic nanoparticles decorated with a POEGMA-based shell has not been 
previously reported. 
The spatial and temporal controlled-release of drugs for improved pain 
management is a major challenge for its adequate treatment. Bupivacaine hydrochloride 
is a local anesthetic that blocks the generation and conduction of nerve impulses. It is 
widely used in epidural infusions to provide post-operative analgesia [37, 38], and for 
Caesarean sections [39]. Bupivacaine hydrochloride has been demonstrated to have 
long-term stability [40, 41], thus it has been previously chosen as a model drug to be 
incorporated within nanoparticulate carriers for the treatment of chronic pain. In a 
preceding study, Dihn et al. [42] incorporated bupivacaine in poly(lactic-co-glycolic 
acid) (PLGA) NPs within collagen-based injectable composite hydrogels in which the 
release could be controlled by changing the ratio of the different monomeric 
components. Microparticles composed of PLGA were also applied for controlled 
bupivacaine release showing no cytotoxicity or proinflammatory effects [43]. PNIPAM-
based nanogels exhibited ionic affinity for binding bupivacaine which produced an 
effective drug loading [44] and achieved nerve block durations of up to 9h [45]. Herein, 
HGNPs with NIR optical properties are functionalized with a thermoresponsive 
OEGMA-based copolymer shell to be used as drug carriers for the controlled delivery 
of an entrapped drug under external stimuli. HGNPs act as NIR light absorbing 
materials suitable for photothermal triggered drug delivery. The loading and the release 
profiles of the local anesthetic bupivacaine were determined to study the nanoparticles 
efficiency and the effect of the light/temperature stimuli in the release process. 
 
2. Experimental Section 
2.1. Materials and methods 
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Di(ethylene glycol) methyl ether methacrylate (MEO2MA)  (95%), 
oligo(ethylene glycol) methyl ether methacrylate (OEGMA) (Mn 500 g mol-1), 
2,2bipyridyl (bipy) (98%), bis[2-(2-bromoisobutyryloxy)undecyl] disulfide (97%), 
anhydrous ethanol (Panreac, 0.02% water), cobalt chloride hexahydrate (ACS reagent 
grade), sodium citrate tribasic dihydrate (≥98%), poly(vinylpyrrolidone) (PVP, Mw = 
55000 Da), sodium borohydride (≥99%), gold(III) chloride hydrate (~50% Au basis), 
ammonium persulfate (APS) (>98%), ethylene glycol dimethacrylate (EGDMA) 
(>98%), sodium dodecyl sulfate (SDS) (>98%) and bupivacaine hydrochloride 
monohydrate (≥99%) were purchased from Sigma-Aldrich. All of these chemicals were 
used as received. Copper(I) chloride (Sigma Aldrich, 97%) was washed with glacial 
acetic acid and ethanol and dried to remove oxidized species before use.  
Proton nuclear magnetic resonance (1H-NMR) spectroscopy was carried out on a 
Bruker AV-400 spectrometer operating at 400 MHz using CDCl3 as solvent. Fourier 
transform infrared (FTIR) spectroscopy analysis was performed on a Bruker Vertex 70 
FTIR spectrometer equipped with a deuterated triglycine sulfate (DTGS) detector and a 
Golden Gate diamond attenuated total reflectance (ATR) accessory. The scans were 
performed in the wavelength range of 4000-400 cm-1. Thermogravimetric analysis 
(TGA; Mettler Toledo TGA/STDA 851e) was carried out in a temperature range 
between 30 and 800 ºC using a heating rate of 10 ºC/min under nitrogen atmosphere. 
The LCST of the polymer solutions (3 mg mL-1) in deionized water was 
determined from the optical transmittance measurements at 670 nm as a function of 
temperature using a Varian Cary® 50 UV-Visible spectrometer (Agilent Technologies, 
USA) equipped with an optic fiber dip probe. UV-vis spectra were recorded using a 
Jasco V670 spectrophotometer to evaluate the characteristic HGNPs surface plasmon 
resonance band in the NIR region of the electromagnetic spectrum. Dynamic light 
scattering (DLS) measurements and analysis were performed on a Brookhaven 90Plus 
particle size analyzer with a detection angle of 90º. Measurements were taken at 25 ± 
0.1 ºC. Zeta potential of the nanoparticles was measured in the same equipment using 
the ZetaPALS software in 1 mM KCl aqueous solution at a pH = 6 and 25 ± 0.1 ºC. 
Transmission electron microscopy (TEM) images were recorded on a T20-FEI 
Tecnai thermoionic microscope operated at an acceleration voltage of 200 kV. 
Aberration corrected scanning transmission electron microscopy (Cs-corrected STEM) 
images were acquired using a high angle annular dark field detector (HAADF) in a FEI 
XFEG TITAN electron microscope operated at 300 kV equipped with a CETCOR Cs-
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probe corrector from CEOS. Elemental analysis was carried out with an EDS (EDAX) 
detector, which allows performing EDS experiments in the scanning mode. Samples 
were dropped in carbon coated copper grids, dried at room temperature and stained with 
a negative staining agent (phosphotungstic acid) when necessary to improve the contrast 
of the thermoresponsive polymeric shell.  
Nanoparticle irradiation was performed using a 808nm-laser diode (model 
MDL-III-808-2W, Changchun New Industries Optoelectronics Technology Co., Ltd., 
Changchun, P.R. China). Samples were irradiated as dispersions in water at a 
concentration of 1.6 mg/mL using a laser irradiance of 6.5 W/cm2. 
 
2.2. Synthetic procedures 
2.2.1. Synthesis of disulfide-P(MEO2MA-co-OEGMA500)  
The thermoresponsive disulfide-P(MEO2MA-co-OEGMA500) polymer was 
prepared by ATRP using a CuCl/bipy complex as catalyst. The synthesis was performed 
in ethanol at 60 ºC using the disulfide-functionalized bis[2-(2-
bromoisobutyryloxy)undecyl] disulfide initiator, adapted from the method described by 
Lutz and Hoth [30] using a molar ratio [monomers]0/[Initiator]0/[CuCl]0/[bipy]0 = 
100/1/1/2. The MEO2MA / OEGMA500 monomer ratio used was (88/12) to adjust the 
LCST within the physiological temperature [46]. The final product was purified by 
passing the ethanolic solution containing the resulting polymer through a silica gel (60-
120 mesh) column. Then, the solvent was further removed using a rotary evaporator, 
and the polymer was dispersed in water and dialyzed (molecular weight cut-off 14000 
Da) against water/ethanol mixtures for at least 72 h to ensure the removal of the non-
reacted monomers. Finally, water was removed by lyophilization to yield the polymer 
as a colorless oil. 
 
2.2.2. Synthesis of hollow gold nanoparticles (HGNPs)  
The synthesis of HGNPs was performed using previously reported methods [47, 
48]. Briefly, in a two-necked round-bottom flask, 400 mL of deionized water was 
combined with 400 L of 0.35 M cobalt chloride hexahydrate and 1.6 mL of 0.1 M 
sodium citrate trihydrate. The solution was deoxygenated by bubbling it with argon gas 
for 45 minutes with no magnetic stirring. To that solution, 2 mL of 1 wt.% solution of 
poly (vinylpyrrolidone) and 400 L of 1.0 M sodium borohydride was added under 
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magnetic stirring, and the solution turned to brown indicating the formation of cobalt 
nanoparticles. The cobalt nanoparticle dispersion was further stirred under argon flux 
during 15 minutes. Afterwards, 380 mL of the cobalt nanoparticle dispersion was added 
to a solution containing 120 mL of deionized water and 180 L of 0.1 M gold (III) 
chloride hydrate under stirring. The final dispersion was stirred at ambient conditions 
during 30 minutes to complete the oxidation of the residual cobalt, thus the dispersion 
turned from brown to green indicating the presence of HGNPs. The resulting dispersion 
was centrifuged at 13000 rpm several times to remove potential unreacted reagents. 
 
2.2.3. Grafting of disulfide-P(MEO2MA-co-OEGMA500) polymer to HGNPs 
HGNPs were coated with the disulfide-functionalized P(MEO2MA-co-
OEGMA500) polymer. The strong interaction between the disulfide end-group of the 
polymer and the gold surface of the nanoparticles allows the covalent and electrostatic 
attachment of the polymer to the nanoparticles [49, 50]. A dispersion of the polymer 
and the HGNPs in a weight ratio (1:1) was stirred during 3 h at room temperature. 
Afterwards the excess of polymer was washed by centrifugation with water (3 times, 
13000 rpm).  
 
2.2.4. Synthesis of HGNPs@P(MEO2MA-co-OEGMA500) core-shell nanogels 
HGNPs@P(MEO2MA-co-OEGMA500) were used as starting material to tailor a 
thick nanogel shell on the surface of the nanoparticles. The synthesis was done using the 
nanoprecipitation polymerization method based on the protocol reported by 
Guarrotxena et al. [51] Briefly, a typical synthesis was depicted as follows: in a Schlenk 
tube, 4.5 mg of as-prepared P(MEO2MA-co-OEGMA500) capped HGNPs, 0.546 mmol 
of MEO2MA monomer, 0.0745 mmol of OEGMA500 monomer, 0.0185 mmol of 
EGDMA cross linker and 5.2x10-3 mmol of SDS surfactant dissolved in 9 mL of 
deionized water were purged with argon under stirring during 30 min. The 
[MEO2MA]/[OEGMA500] monomer molar ratio used was 88/12, to maintain the LCST 
in the physiological range [46]. After purging, the solution was heated to 65 ºC, and the 
polymerization was initiated by the addition of APS (450 μL, 0.035 M). As the 
nanoprecipitation polymerization starts, the transparent solution became cloudy. The 
polymerization was carried out during 2 h and after, the obtained nanoparticles were 
centrifuged and washed with water three times (2000 rpm, 10 min) to remove unreacted 
reagents. 
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2.3. Cell culture and biological studies 
The cytocompatibility of the HGNPs@P(MEO2MA-co-OEGMA500) and 
HGNPs@P(MEO2MA-co-OEGMA500) loaded with bupivacaine was evaluated at 
different levels regarding metabolism, cell membrane (induction of apoptosis and/or 
necrosis) and cell nucleus (distribution of cell-cycle phases). These studies were 
developed in mouse mesenchymal stem cells (mMSCs) and in human glioblastoma cells 
(U251MG), both kindly gifted by Dr. Pilar Martín-Duque, as well as in human dermal 
fibroblasts (Lonza, Belgium) and in THP1 human macrophages (American Type 
Culture Collection, US).  
Fibroblasts and U251MG cells were grown in DMEM high glucose (Biowest, 
France) containing 2 mM L‐glutamine and supplemented with 10% v/v fetal bovine 
serum (Gibco, UK) and 1% penicillin-streptomycin‐amphotericin B (Biowest, France), 
while mMSCs were cultured in DMEM-F12 (Biowest, France) supplemented with 2 
mM L-glutamine (Biowest, France), 10% v/v fetal bovine serum (Gibco, UK) and 1% 
penicillin-streptomycin‐ amphotericin B (Biowest, France). Monocytes were cultured in 
RPMI 1640 (Biowest, France) also containing 2 mM L‐glutamine and supplemented 
with 10% v/v fetal bovine serum (Gibco, UK), 1% HEPES, 0.1% 2‐mercaptoethanol 50 
mM, 1% non‐essential aminoacids, 1% sodium pyruvate 100 mM and 1% 
penicillin‐streptomycin‐amphotericin B (Biowest, France). Macrophages were obtained 
by the in vitro differentiation of monocytes through the addition of 1 μM phorbol 
12‐myristate 13‐acetate (Sigma Aldrich, US) to the cell culture medium for 72 h. All 
cell types were cultured at 37 ºC and 5% CO2, except for mMSCs (hypoxia conditions, 
3% O2). 
 
2.3.1. Cell viability assay  
Blue Cell Viability assay (Abnova, Taiwan), which is based on the reduction of 
a dye to a fluorescent compound mediated by metabolically active cells, was used to 
determine the effects of our hybrid thermoresponsive nanoparticles on cell metabolism 
after incubation (0.02‐ 2 mg/mL) for 24 h. Then, the reagent was added to the cells 
(10%) and incubated for 4 h (37 ºC, 5% CO2). After incubation, fluorescence was read 
(535/590 nm ex/em) in a Synergy HT Microplate Reader (Biotek, US) and viability was 
calculated by interpolation of the emission data displayed by the treated samples and the 
control ones (untreated samples = 100% viability). 
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2.3.2. Evaluation of early and late cell apoptosis and necrosis 
In order to evaluate the influence of the nanoparticles in the physiological state 
of different cell lines (U251MG, Fibroblasts, mMSCs and THP1 macrophages), a 
quantitative analysis of cell death by apoptosis and necrosis was carried out using a 
commercial kit (Annexin V FITC kit, Immunostep) according to the manufacturer’s 
instructions. Briefly, cells were treated with nanoparticles (0.2 mg/mL, subcytotoxic 
concentration obtained from the Blue Cell Viability assay) for 24 h at 37° C and 5% 
CO2. After nanoparticle exposure, cells were washed twice with PBS and harvested by 
centrifugation (1500 rpm, 5 min). Then, cells were resuspended in PBS at final 
concentration of 106 cells/mL. Subsequently, cells were centrifuged at 1200 rpm for 5 
min and the pellet was resuspended in 100 μl of Annexin-binding buffer. Then, 50 μl of 
this cell suspension was stained with Annexin V-FITC and propidium iodide for 15 min 
at room temperature in the dark. After incubation, 150 μl Annexin-binding buffer was 
added to each sample. Samples were immediately analyzed via flow cytometry in a 
FACSARIA BD equipment and the percentages of alive, apoptotic and necrotic cells 
were calculated using the FACSDIVA BD software (Cell Separation and Cytometry 
Unit, CIBA, IIS Aragon, Spain). 
 
2.3.3. Cell Cycle analysis  
Cell cycle analysis was carried out by flow cytometry using propidium iodide 
DNA staining. For that, cells exposed to 0.2 mg/mL nanoparticles for 24 h were 
collected, fixed with 70% ice-cold ethanol and stored at 4 ºC for 24 h. Cells were then 
centrifuged, washed in PBS and treated with a solution containing RNase A 
(100 μg/mL; Sigma-Aldrich) and propidium iodide (50 μg/mL; Sigma-Aldrich). After 
an incubation period of 30 min at room temperature in the dark, samples were analyzed 
in a Gallios flow cytometer. 
 
 
3. Results and discussion 
3.1. Characterization of the polymer  
The PEGylation of nanoparticles is widely used in biomedical applications as 
PEG is non-toxic and acts as dispersing agent reducing protein adsorption and the fast 
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clearance by the mononuclear phagocyte system. Here, the disulfide-P(MEO2MA-co-
OEGMA500) copolymer coated on the surface of the HGNPs contributes to achieve 
water dispersity and enhances the core-metal biocompatibility. Moreover, the polymer 
provides with a thermoresponsive behavior to the Au-based nanoparticles, to be used as 
thermally-responsive drug delivery systems. The LCST of the synthesized polymer was 
defined as the temperature at which 50% of the initial transmittance and it was reached 
[52] by adjusting during the ATRP the molar ratio of the monomers in the final 
structure. In Fig. 1a the polymer shows a LCST of 41.5 ºC with an OEGMA molar 
content of 12%. The transmittance curve presented a sharp decrease, which is consistent 
with a monodisperse distribution of molecular weights in the polymer. This coil-globule 
transition was tuned above the physiological temperature to a value (41.5 ºC) that could 
be easily reached thanks to the photothermal heating produced by the HGNP absorption 
of light in the NIR region. The structure of the disulfide-P(MEO2MA-co-OEGMA500) 
was corroborated by 1H-NMR spectroscopy, shown by the new signal at 4.1 ppm 
characteristic of the polymer formation, and the absence of vinyl protons characteristic 
of the free monomers (5.57 and 6.13 ppm) after purification (Fig. 1b). Fig. 1b shows the 
principal resonance peaks of the disulfide-terminated polymer obtained. The disulfide 
end-functionalized polymer is characterized by the following peaks: the ones present at 
0.9-1.5 ppm which correspond to the protons of the (-C-(CH2)9-C-) group of the 
initiator. The peaks at 4.1, 3.5-3.7 and 3.4 ppm correspond to the main chain protons of 
the chemical groups (CH2-CH2-O), (-CH2-O-) and (-OCH3), respectively, and peaks at 
1.7-2 and 0.85 ppm are related to the first and second protons of (-CH2C(CH3)), 
respectively [53]. The FTIR spectra of the disulfide-P(MEO2MA-co-OEGMA500) 
polymer depicted in Fig. 1c showed the characteristic band at 2880 cm-1 attributed to C-
H stretching vibrations [54]. The peak at 1720 cm-1 was assigned to the stretching 
vibration of C=O groups in the polymer, and the broad band at 1109 cm-1 corresponds 
to C-O-C stretching vibrations [55]. 1H-NMR and FTIR signals in Fig. 1 confirmed that 
the disulfide-P(MEO2MA-co-OEGMA500) copolymer was obtained. These disulfide 
groups were used to covalently bind the resulting themoresponsive polymer to gold 
surfaces via electrostatic and covalent coupling [56]. 
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Fig. 1. (a) Transmittance at 670 nm versus temperature for 3 mg/mL disulfide-P(MEO2MA-co-
OEGMA500) polymer solution. (b) 
1H NMR spectra of disulfide-P(MEO2MA-co-OEGMA500) copolymer. 
(c) FTIR of disulfide-P(MEO2MA-co-OEGMA500) copolymer. The LCST was set at 41.5 ºC with a 
MEO2MA/OEGMA500 ratio of 88:12. 
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Scheme 1. Synthetic route of HGNPs@P(MEO2MA-co-OEGMA500) monolayer and 
HGNPs@P(MEO2MA-co-OEGMA500) nanogel. 
 
3.2. Preparation of hybrid HGNPs@P(MEO2MA-co-OEGMA500) core-shell 
nanoparticles 
Scheme 1 represents the synthetic route for the preparation of HGNPs@P(MEO2MA-
co-OEGMA500) and HGNPs@P(MEO2MA-co-OEGMA500) nanogels. As-prepared 
HGNPs were functionalized with the copolymer P(MEO2MA-co-OEGMA500) through 
the interaction with the disulfide end group of the polymer. Afterwards, HGNPs coated 
with P(MEO2MA-co-OEGMA500) were used as starting materials for the synthesis of 
nanogel-composed shells grown onto the nanoparticle surface using the 
nanoprecipitation polymerization method described above (Scheme 1). Fig. 2a shows 
TEM images of the resulting HGNPs@P(MEO2MA-co-OEGMA500) after staining with 
phosphotungstic acid salt to show the thickness (i.e., 9 nm) of the polymeric shell. TEM 
images revealed the presence of monodisperse nanoparticles of approx. 40 nm in 
diameter. In Fig. 2b STEM-HAADF images showed a stained sample to identify the 
location of Au and W atoms by Z–contrast, where W atoms represented the polymeric 
shell due to the dye used [57]. The polycrystalline structure of the metal nanoparticles is 
observed in images Fig. 2c-e, where the hollow structure is described in detail. TEM 
and STEM-HAADF images of HGNPs@P(MEO2MA-co-OEGMA500) nanogels are 
presented in Fig. 2g-h. The core-shell nanogels are spheroidal in shape with single gold 
cores homogeneously encapsulated in the nanogel shell. The overall average particle 
diameter was 206.5 ± 49.3 nm (N=15) with a nanogel shell thickness of ≈ 60 nm. The 
EDS analysis (Fig. 2f,i) showed the presence of atoms of Au, C and O (and Cu due to 
the copper grid used). Co atoms were not detected indicating a successful galvanic 
replacement of Co by Au during the formation of the HGNPs. 
Between these two types of hybrid core-shell nanoparticles we selected HGNPs 
functionalized with the thin polymeric shell monolayer, referred to as 
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HGNPs@P(MEO2MA-co-OEGMA500) hereafter, for the bupivacaine loading and 
release studies. The average hydrodynamic diameter of HGNPs@P(MEO2MA-co-
OEGMA500) determined by DLS was 65 nm with a polydispersity index of 0.2 which is 
consistent with the results retrieved from the TEM images. 
 
 
Fig. 2. Electron microscopy analysis of HGNPs@P(MEO2MA-co-OEGMA500) monolayer: (a) TEM 
images of a sample stained with a heavy metal phosphotungstic acid salt, used as a negative stain, to 
allow electronic observation of the polymer coating. Inset, a detailed TEM image to observe the polymer 
shell of aprox. 9 nm. (b-d) STEM-HAADF images of a stained sample to observe the location by Z –
contrast of Au and W atoms. W atoms stained the polymeric shell. e) UHR-STEM-HAADF image to 
observe the polycrystalline structure of HGNPs. Inset is a detailed UHR-STEM-HAADF image of a pore 
in the HGNPs. (f) EDS analysis in the red-line area marked in d). Electron microscopy analysis of 
HGNPs@P(MEO2MA-co-OEGMA500) nanogel: (g) TEM Images of a sample stained with 
phosphotungstic acid salt. Inset, a detailed TEM image to observe the polymer shell of approx. 60 nm. (h) 
STEM-HAADF images of a stained sample to observe the location by Z –contrast of Au and W atoms. W 
atoms stained the polymeric shell. (i) EDS analysis in the red-line areas marked in h) to differentiate the 
core and shell chemical composition. 
 
 
HGNPs@P(MEO2MA-co-OEGMA500) presented a maximum in the extinction 
spectrum at 814 nm as shown in Fig. 3a. The surface plasmon resonance (SPR) band of 
the gold nanoparticles was red-shifted 27 nm to the NIR region after functionalization 
with the polymer, due to changes in the shell dielectric constant and its thickness [58, 
59]. Therefore the modified nanoparticles could be activated by 808nm-NIR laser 
irradiation to generate the heat required to activate the phase transition of the polymer 
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covalently coupled to their surface. The nanoparticle polymer content was determined 
by TGA in the temperature range from 30 to 600 ºC. Fig. 3b shows the weight loss of 
the NPs as a function of the temperature. The thermal decomposition of P(MEO2MA-
co-OEGMA500) occurred between 200-420 ºC. The polymeric content corresponding to 
the weight loss in that temperature range was a 10 wt.%. The FTIR analysis 
corroborated the functionalization of the HGNPs with the polymer by the identification 
of the characteristic bands of the polymer (Fig. 3c), the broad band at 1109 cm-1 
corresponds to the C-O-C stretching vibration and the 1720 cm-1 peak was ascribed to 
the stretching vibration of the C=O group of the polymer [55]. The stability of the 
resulting NPs was corroborated by demonstrating that the Zeta Potential value of the 
colloidal aqueous suspensions remained unvaried over several months of storage 
(results not shown) without showing any signs of agglomeration. 
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Fig. 3. (a) UV-Visible spectra of HGNP@P(MEO2MA-co-OEGMA500) and HGNPs. (b) 
Thermogravimetric analysis of HGNP@P(MEO2MA-co-OEGMA500) (c) FTIR of HGNP@P(MEO2MA-
co-OEGMA500) and P(MEO2MA-co-OEGMA500) copolymer. 
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bupivacaine solution was added into an Eppendorf tube® containing 1.6 mg of 
lyophilized HGNPs@P(MEO2MA-co-OEGMA500). The mixture was kept under stirring 
at room temperature for 4 h, and then the dispersion was centrifuged at 13000 rpm 
during 12 min to separate the nanoparticles, and carefully washed with 1 mL of 
additional water. The amount of bupivacaine loaded in the nanoparticles was 
determined indirectly determining the amount of drug remaining in the supernatant after 
loading, using UV-visible spectroscopy to quantify the bupivacaine at the detection 
wavelength of 262 nm. Drug loading was calculated by the following equation:    
                             
                          
        
Drug loading content determined spectrophotometrically was (3.0 ± 0.4) wt.%.  
Zeta potential was used to study the nature of the interactions between the 
HGNPs@P(MEO2MA-co-OEGMA500) surface and bupivacaine. Bupivacaine 
hydrochloride is positively charged at neutral pH (pKa=8.1) and therefore, it can 
interact electrostatically with a negatively charged surface. Zeta potential measurements 
performed on HGNP@P(MEO2MA-co-OEGMA500) revealed a negative electrokinetic 
potential of -11.34 ± 1.10 mV in the nanoparticles (Fig. 4a), attributed to the sodium 
citrate used to stabilize the NPs and to the ethylene oxide groups of the P(MEO2MA-co-
OEGMA500) polymer. HGNP@P(MEO2MA-co-OEGMA500) loaded with bupivacaine 
reduced their zeta potential to -4.2 ± 1.10 mV, pointing to a partial neutralization of the 
polymer negative charges by electrostatic interaction with bupivacaine. To evaluate the 
type of interaction nanoparticles loaded with bupivacaine were incubated in PBS buffer 
(as a competitive high ionic strength media) during 24 h, having an identical release 
profile than that achieved in deionized water. Therefore, through this assay we 
dismissed that binding of bupivacaine to NPs was driven exclusively by ionic 
interactions, so nonspecific absorption and hydrophobic interactions also contributed to 
drug encapsulation. Other authors pointed to both contributions using PNIPAM 
nanogels scavengers for bupivacaine [44].  
In vitro release profiles of bupivacaine from HGNPs@P(MEO2MA-co-
OEGMA500) dispersed in water were examined at physiological temperature, 37 ºC, 
which produces an expanded coil conformation of the polymer, below its LCST; and 
also at 45 ºC where the polymer would be organized in the collapsed globular 
conformation. Drug release induced by the reversible polymer phase transition was 
tested by monitoring the release under sequential heating pulses above (45 ºC) and 
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below (37 ºC) the LCST of the polymer. NPs loaded with bupivacaine were re-dispersed 
in 1 mL of water immediately after loading. The dispersions were then placed into a 
thermoshaker with mechanical agitation at 600 rpm at the temperature required (37 or 
45 ºC) according to each assay. As shown in Fig. 4b, the drug release rate of 
HGNPs@P(MEO2MA-co-OEGMA500) was faster at 45 ºC than at physiological 
temperature (37 ºC). At high temperature (45 ºC), the cumulative drug released was 
considerably higher than that obtained at 37 ºC (Fig. 4b), probably due to a higher 
diffusion and favored desorption promoted by the increase in the temperature. The 
cumulative drug release data were fitted to mathematical models to elucidate the 
mechanism controlling bupivacaine delivery. The correlation coefficient (r) was 
determined from the linear regressions to zero order and Higuchi model. The release 
profile at 37ºC showed an r value of 0.976 and 0.998 for the fitting to zero order and 
Higuchi model, respectively. The release at 45 ºC also showed a better correlation to 
Higuchi model (Zero order r=0.989, Higuchi r=0.999). This indicates that the release 
process is controlled mainly by diffusion of the drug, as was shown previously in other 
nanoparticle-based systems [61]. When the temperature was varied above and below the 
LCST, in a pulsed release mode, the accumulated released drug from nanoparticles was 
quickly enhanced (Fig. 4b). The results clearly show that the pulsed release improves 
drug delivery on-demand, giving a much faster release rate. After 12 pulses, the 
cumulative diffusive release reached a 40% of the drug loaded, in less than 8 h, 
conversely bupivacaine release at 37 ºC took more than 160 h to obtain such cumulative 
drug release. Moreover, the doses of drug released were spatiotemporally controlled by 
the number of pulses supplied. The reason for these results is that the transition across 
the LCST causes the physical change of the polymer, to give a hydrophobic structure 
able to expel a fraction of the drug retained in the inner shell of the polymer. As it is 
shown in Fig. 4b, the amount of drug released followed a linear relationship with the 
number of pulses applied, due to a burst release as opposed to a diffusion-controlled 
release occurred at 37 ºC. 
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Fig. 4. (a) Zeta potential of HGNP@P(MEO2MA-co-OEGMA500) and HGNP@P(MEO2MA-co-
OEGMA500) loaded with bupivacaine (b) Bupivacaine release profiles from HGNP@P(MEO2MA-co-
OEGMA500) at different temperatures: 45 ºC, 37 ºC and pulses of temperature from 37 ºC to 45 ºC (the 
star corresponds to 10 cycles of irradiation). Percentages are displayed as mean ± SD (N = 3). (c) Heating 
curve of HGNP@P(MEO2MA-co-OEGMA500) dispersed in water with a concentration of 1.6 mg/mL and 
laser irradiance of 6.5 W/cm2.  
 
The photothermal response caused by HGNPs surface plasmon excitation upon 
808 nm laser irradiation was also used to induce changes in the temperature from 37 ºC 
to 45 ºC. Fig. 4c shows the heating curves of 1.6 mg/mL nanoparticle dispersion in 
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water under a laser irradiance of 6.5 W/cm2 (such high irradiance was used to obtain a 
fast response). After ten cycles, the temperature profiles showed no significant 
difference between the different irradiation cycles, indicating enhanced photostability of 
the HGNPs (Fig. 4c). Each pulse of temperature took around 7 minutes to complete, and 
after ten irradiation pulses in a sample incubated during 4 days at 37 ºC, the amount of 
drug released was determined spectrophotometrically. Controls made under the same 
conditions using water or PBS alone showed no heating after irradiation. Results in Fig. 
4b (highlighted with an arrow), showed that the amount of drug released was a 12% 
higher when the photothermal stimulus was applied to trigger the release compared to 
the release obtained at 37 ºC. Thus, in case of a real application, a triggered on-demand 
release at specific time point can be achievable to provide with an extra of analgesia by 
using the nanoparticles here reported. We thus demonstrated that under NIR light 
irradiation the photothermal-induced reversible transition from coil to globule in the 
polymer can be used to provide with a stimulus-responsive triggered release of 
bupivacaine to improve pain management.  
 
3.4. Cell viability assay  
 The cytocompatibility of the hybrid thermoresponsive materials synthesized was 
studied at different levels (cell metabolism, cell membrane and DNA) in four cell lines 
(human dermal fibroblasts, mMSCs, U251MG and human macrophages).  
The treatment of the cell lines incubated with our particles (0.02-2 mg/mL) 
involved detrimental effects on cell metabolism and viability at the higher 
concentrations assayed as was determined by the Blue Cell Viability assay (Fig. 5). The 
increase in HGNPs@P(MEO2MA-co-OEGMA500) concentration (Fig. 5a) implied a 
decrease in viability higher than 50% at concentrations from 1 mg/mL in all the cell 
types studied, being less accentuated for U251MG. At the highest concentration assayed 
(2 mg/mL), the viability percentages obtained were between 31% (mMSCs) and 42% 
(U251MG). The addition of HGNPs@P(MEO2MA-co-OEGMA500) loaded with 
bupivacaine to the cell cultures (Fig. 5b) displayed similar viability percentages to those 
obtained in the case of the non-loaded particles, except for macrophages that exerted 
higher values. In this case, the percentages obtained at the higher concentration studied 
were between 33% (mMSCs) and 80% (macrophages). Taking into account these 
results and the recommendations of the ISO 10993-5 [62], 0.2 mg/mL was considered 
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the subcytotoxic concentration for further studies as this concentration displayed 
viability percentages higher than 70% in all the cell lines assayed and for both materials 
evaluated. 
 
 
Fig. 5. Cell viability of HGNPs@P(MEO2MA-co-OEGMA500) (a) and HGNPs@P(MEO2MA-co-
OEGMA500) loaded with bupivacaine (b), in the four cell lines assayed after 24 h. Percentages are 
displayed as mean ± SD (N = 5) 
 
 In order to obtain information about the effect of nanoparticles 
(HGNPs@P(MEO2MA-co-OEGMA500) on cell cycle progression and cell population 
distribution, we performed cell cycle analysis by flow cytometry. The results obtained 
from the cell cycle analysis are shown in Fig. S1. No significant nanoparticle-induced 
perturbation of the cell-cycle distribution were observed in THP1 macrophages and 
U251MG at subcytotoxic concentration (0.2 mg/mL), indicating nanoparticles do not 
deregulate the cell cycle and, therefore, they did not interfere with cell division or with 
cellular functions in these cell lines studied. In addition, no significant differences were 
observed in the degree of necrosis and both early and late apoptosis in THP1 
macrophages and U251 MG cells after nanoparticle exposure (Table S1). In human 
dermal fibroblasts, an increase in G1 population accompanied by a marked decrease in 
G2 population compared to that observed for the control was measured after 
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nanoparticle treatment. However, S population was not affected as compared to that of 
the corresponding control. These data might suggest that nanoparticles could cause cell 
cycle arrest in G1 phase (Fig. S1). However, it is important to mention that no 
significant changes in the percentages of apoptotic and necrotic cells were observed 
after nanoparticle treatment at subcytotoxic concentration in this cell line (Table S1). In 
contrast to human dermal fibroblasts, in mMSCs, a marked increase in the percentage of 
cells in G1 phase with a concomitant decrease in G2 population were observed after 24 
h of treatment with nanoparticles by comparison with control cells, indicating a possible 
cell cycle arrest at G2 phase (Fig. S1). In this case, nanoparticle exposure caused a 
slight increase in the percentage of early apoptotic cells (Table S1). These results 
indicated that the nanoparticle-induced cell cycle perturbations seem to be dependent on 
the cellular type. Thus, in fibroblasts, the addition of nanoparticles might retard cell 
proliferation without inducing cell death, probably acting as cytostatic agent. While in 
mMSCs, nanoparticles could suppress the progression of cell cycle at G2 phase. The 
data also suggest that only a small population of cells is undergoing cell death by 
apoptosis while higher percentage is alive. Furthermore, according to the 
recommendations indicated above of the American National Standard ISO 10993-5, 
HGNPs@P(MEO2MA-co-OEGMA500) nanoparticles showed appropriate 
biocompatibility for biomedical applications due to that their cytotoxic effect on cells 
was always lower than 30%.  
To our knowledge this is the first report in the literature describing the 
functionalization of HGNPs with the thermoresponsive polymer disulfide-P(MEO2MA-
co-OEGMA500) and, therefore, there is not previous data about the potential effects of 
these surface-functionalized nanoparticles on cell viability, cell cycle steps, apoptosis or 
necrosis. Due to the easy of functionalization of gold nanoparticles with thiolated 
chains, PEG is one of the most used biocompatible molecules for increasing the 
biocompatibility of gold nanomaterials. Several studies have described the influence of 
PEGylated gold nanoparticles on cell metabolism, cell cycle progression [63, 64] and in 
the induction of apoptosis [64] in both healthy and cancer cell lines. Regarding cell 
viability, these studies reported similar effects in the cell types assayed as those showed 
by our previously reported HGNPs, pointing to 0.1 mg/mL as the subcytotoxic 
concentration [63], while a concentration of 10 mM (2 mg/mL) PEG-AuNPs was 
clearly harmful for human chronic myeloid leukemia cell line K562 exerting viability 
percentages around 20% [64]. Also, a previous study showed that the interaction of 
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nanoparticles on cell cycle varied depending on both cell line and nanoparticle type. 
Thus, independent of their surface properties, PEGylated gold nanoparticles caused 
significant cell-cycle perturbation on several cancer cells without causing any apoptotic 
behavior [65] but, however, in healthy fibroblasts, the effect of PEGylated gold 
nanoparticles was dependent on PEG grafting density and hydrodynamic volume. Given 
that the effect of nanoparticles on cell cycle progression, apoptosis or necrosis may 
depend on the nature of the thermoresponsive polymer coating in the surface of gold 
nanoparticles. It is important to mention that OEGMA-based copolymers have been 
reported as non-cytotoxic at the highest concentration tested (i.e., 0.4 mg/mL) [46]. 
 
4. Conclusions 
In summary, HGNPs surface functionalized with the thermoresponsive polymer 
disulfide-P(MEO2MA-co-OEGMA500) were fabricated and tested as drug delivery 
systems. The local anesthetic bupivacaine was loaded in the nanoparticles, obtaining a 3 
wt.% drug loading. Drug-release results indicated that HGNPs@P(MEO2MA-co-
OEGMA500) show thermoresponsive behavior and controllable release when treated 
above and below the LCST of the polymer. The spatiotemporal control of the drug 
release is achievable thanks to the polymer transition from coil to globule produced by 
photothermal heating. This feature is very attractive when using these NPs in 
biomedical applications such as on-demand drug delivery. In addition the biological 
studies highlighted their cytocompatibility at concentrations up to 0.2 mg/mL. Results 
demonstrated that NIR photoactivated HGNPs functionalized with the 
thermoresponsive P(MEO2MA-co-OEGMA500) could have great potential for on-
demand  controlled release of bupivacaine potentially used in the treatment of chronic 
pain.  
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